Induction chemotherapy with docetaxel, cisplatin and s-1 followed by proton beam therapy concurrent with cisplatin in patients with t4b nasal and sinonasal malignancies

Japanese Journal of Clinical Oncology

Volumn 42, Issue 8, 2012, Pages 691-696

  Okano, Susumu ^a,b   Tahara, Makoto ^a   Zenda, Sadamoto ^a   Fuse, Nozomu ^a   Yoshino, Takayuki ^a   Doi, Toshihiko ^a   Kawashima, Mitsuhiko ^a   Ogino, Takashi ^a   Hayashi, Ryuichi ^a   Ohtsu, Atsushi ^a  

^a NATIONAL CANCER CENTER HOSPITAL EAST   (Japan)

^b JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Head and neck; Induction chemotherapy; Nasal; Proton; Sinonasal

Indexed keywords

CIPROFLOXACIN; CISPLATIN; DOCETAXEL; GIMERACIL PLUS OTERACIL POTASSIUM PLUS TEGAFUR;

ADULT; ANEMIA; ANOREXIA; ANTINEOPLASTIC ACTIVITY; ARTICLE; CHEMORADIOTHERAPY; CLINICAL ARTICLE; DIARRHEA; DRUG EFFICACY; FEASIBILITY STUDY; FEBRILE NEUTROPENIA; FEMALE; HEAD AND NECK CANCER; HUMAN; INFECTION; LEUKOPENIA; MALE; MUCOSA INFLAMMATION; MULTIPLE CYCLE TREATMENT; NAUSEA; NEUTROPENIA; PALLIATIVE THERAPY; PROTON THERAPY; RETROSPECTIVE STUDY; THROMBOCYTOPENIA; VOMITING;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMORADIOTHERAPY; CISPLATIN; DRUG COMBINATIONS; FEMALE; HUMANS; INDUCTION CHEMOTHERAPY; MALE; MIDDLE AGED; NOSE NEOPLASMS; OXONIC ACID; PARANASAL SINUS NEOPLASMS; PROTONS; TAXOIDS; TEGAFUR;

EID: 84865102467     PISSN: 03682811     EISSN: 14653621     Source Type: Journal    
DOI: 10.1093/jjco/hys096     Document Type: Article

References (20)

1. Roush GC. Epidemiology of cancer of the nose and paranasal sinuses: current concepts. Head Neck Surg 1979;2:3-11.
2. Muir CS, Nectoux J. Descriptive epidemiology of malignant neoplasms of nose, nasal cavities, middle ear and accessory sinuses. Clin Otolaryngol Allied Sci 1980;5:195-211.
3. Dulguerov P, Jacobsen MS, Allal AS, Lehmann W, Calcaterra T. Nasal and paranasal sinus carcinoma: are we making progress? A series of 220 patients and a systematic review. Cancer 2001;92:3012-29.
4. Guntinas-Lichius O, Kreppel MP, Stuetzer H, Semrau R, Eckel HE, Mueller RP. Single modality and multimodality treatment of nasal and paranasal sinuses cancer: a single institution experience of 229 patients. Eur J Surg Oncol 2007;33:222-8.
5. Dulguerov P, Allal AS. Nasal and paranasal sinus carcinoma: how can we continue to make progress? Curr Opin Otolaryngol Head Neck Surg 2006;14:67-72.
6. Daly ME, Chen AM, Bucci MK, et al. Intensity-modulated radiation therapy for malignancies of the nasal cavity and paranasal sinuses. Int J Radiat Oncol Biol Phys 2007;67:151-7.
7. Dirix P, Nuyts S, Geussens Y, et al. Malignancies of the nasal cavity and paranasal sinuses: long-term outcome with conventional or three-dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys 2007;69:1042-50.
8. Hoppe BS, Nelson CJ, Gomez DR, et al. Unresectable carcinoma of the paranasal sinuses: outcomes and toxicities. Int J Radiat Oncol Biol Phys 2008;72:763-9.
9. Kiyota N, Tahara M, Fujii S, et al. Nonplatinum-based chemotherapy with irinotecan plus docetaxel for advanced or metastatic olfactory neuroblastoma: a retrospective analysis of 12 cases. Cancer 2008;112:885-91.
10. Tahara M, Araki K, Okano S, et al. Phase I trial of combination chemotherapy with docetaxel, cisplatin and S-1 (TPS) in patients with locally advanced or recurrent/metastatic head and neck cancer. Ann Oncol 2011;22:175-80.
11. Nishimura H, Ogino T, Kawashima M, et al. Proton-beam therapy for olfactory neuroblastoma. Int J Radiat Oncol Biol Phys 2007;68:758-62.
12. Zenda S, Kohno R, Kawashima M, et al. Proton beam therapy for unresectable malignancies of the nasal cavity and paranasal sinuses. Int J Radiat Oncol Biol Phys 2011;81:1473-8.
13. Chan AW, Liebsch NJ. Proton radiation therapy for head and neck cancer. J Surg Oncol 2008;97:697-700.
14. Resto VA, Chan AW, Deschler DG, Lin DT. Extent of surgery in the management of locally advanced sinonasal malignancies. Head Neck 2008;30:222-9.
15. Truong MT, Kamat UR, Liebsch NJ, et al. Proton radiation therapy for primary sphenoid sinus malignancies: treatment outcome and prognostic factors. Head Neck 2009;31:1297-308.
16. Ando K, Furusawa Y, Suzuki M, et al. Relative biological effectiveness of the 235 MeV proton beams at the National Cancer Center Hospital East. J Radiat Res (Tokyo) 2001;42:79-89.
17. Licitra L, Locati LD, Cavina R, et al. Primary chemotherapy followed by anterior craniofacial resection and radiotherapy for paranasal cancer. Ann Oncol 2003;14:367-72.
18. Lee MM, Vokes EE, Rosen A, Witt ME, Weichselbaum RR, Haraf DJ. Multimodality therapy in advanced paranasal sinus carcinoma: superior long-term results. Cancer J Sci Am 1999;5:219-23.
19. Rosenthal DI, Barker JL, Jr, El-Naggar AK, et al. Sinonasal malignancies with neuroendocrine differentiation: patterns of failure according to histologic phenotype. Cancer 2004;101:2567-73.
20. Weber DC, Chan AW, Lessell S, et al. Visual outcome of accelerated fractionated radiation for advanced sinonasal malignancies employing photons/protons. Radiother Oncol 2006;81:243-9.